347 related articles for article (PubMed ID: 32686149)
1. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
[TBL] [Abstract][Full Text] [Related]
3. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.
Peng L; Ma J; Cui R; Chen X; Wei SY; Wei QJ; Li B
PLoS One; 2014; 9(8):e106164. PubMed ID: 25165975
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.
Li JS; Chen X; Peng L; Wei SY; Zhao SL; Diao TT; He YX; Liu F; Wei QJ; Zhang QF; Li B
PLoS One; 2015; 10(9):e0137049. PubMed ID: 26352670
[TBL] [Abstract][Full Text] [Related]
5. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S
Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through angiopoietin-like protein 4.
Shen X; Weng C; Wang Y; Wang C; Feng S; Li X; Li H; Jiang H; Wang H; Chen J
Genes Dis; 2022 Mar; 9(2):443-455. PubMed ID: 35224159
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and antiproteinuric effects of salvianolic acid A in combined with low-dose prednisone in minimal change disease rats: Involvement of PPARγ/Angptl4 and Nrf2/HO-1 pathways.
Wang X; Qi D; Fu F; Li X; Liu Y; Ji K; Gao Z; Kong L; Yu C; Xie H; Yue G; Zhu H; Liu K; Fan H
Eur J Pharmacol; 2019 Sep; 858():172342. PubMed ID: 31129156
[TBL] [Abstract][Full Text] [Related]
8. miR-499 Ameliorates Podocyte Injury by Targeting Calcineurin in Minimal Change Disease.
Zhang K; Sun W; Zhang L; Xu X; Wang J; Hong Y
Am J Nephrol; 2018; 47(2):94-102. PubMed ID: 29448244
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
10. Inducible ATF3-NFAT axis aggravates podocyte injury.
Zhang H; Liang S; Du Y; Li R; He C; Wang W; Liu S; Ye Z; Liang X; Shi W; Zhang B
J Mol Med (Berl); 2018 Jan; 96(1):53-64. PubMed ID: 29038896
[TBL] [Abstract][Full Text] [Related]
11. Calpain-Mediated Cleavage of Calcineurin in Puromycin Aminonucleoside-Induced Podocyte Injury.
Ding F; Li X; Li B; Guo J; Zhang Y; Ding J
PLoS One; 2016; 11(5):e0155504. PubMed ID: 27171192
[TBL] [Abstract][Full Text] [Related]
12. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Fukuda A; Fujimoto S; Iwatsubo S; Kawachi H; Kitamura K
Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
[TBL] [Abstract][Full Text] [Related]
13. Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy.
Guo K; Pan P; Wu M; Ma Y; Lu J; Chen H
Mol Cell Endocrinol; 2020 Apr; 505():110730. PubMed ID: 31981598
[TBL] [Abstract][Full Text] [Related]
14. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
Fujino T; Hasebe N
BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
[TBL] [Abstract][Full Text] [Related]
15. "Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.
Chugh SS; Clement LC
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F685-F694. PubMed ID: 37795536
[TBL] [Abstract][Full Text] [Related]
16. MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes.
Lang Y; Zhao Y; Zheng C; Lu Y; Wu J; Zhu X; Zhang M; Yang F; Xu X; Shi S; Liu Z
Cell Death Dis; 2019 May; 10(6):401. PubMed ID: 31127093
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation.
Li X; Ding F; Wang S; Li B; Ding J
Sci Rep; 2015 Dec; 5():17694. PubMed ID: 26634693
[TBL] [Abstract][Full Text] [Related]
18. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.
Clement LC; Avila-Casado C; Macé C; Soria E; Bakker WW; Kersten S; Chugh SS
Nat Med; 2011 Jan; 17(1):117-22. PubMed ID: 21151138
[TBL] [Abstract][Full Text] [Related]
19. RANK Deficiency Ameliorates Podocyte Injury by Suppressing Calcium/Calcineurin/ NFATc1 Signaling.
Liang S; Zhang H; Du Y; Dou C; Liu S; Zhang L; Chen Y; Li R; Ma J; Li Z; Lin T; Zhao X; Zhang Q; Wang W; Ye Z; Liang X; Shi W; Zhang B
Kidney Blood Press Res; 2018; 43(4):1149-1159. PubMed ID: 30036881
[TBL] [Abstract][Full Text] [Related]
20. Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase.
Kinugasa S; Tojo A; Sakai T; Tsumura H; Takahashi M; Hirata Y; Fujita T
Kidney Int; 2011 Dec; 80(12):1328-38. PubMed ID: 21849973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
